PubRank

N L Tilney

Author PubWeight™ 201.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971 4.15
2 Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968 3.34
3 Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991 2.46
4 The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997 2.28
5 Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987 2.16
6 Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 1984 2.03
7 The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med 1981 1.94
8 Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med 1975 1.82
9 Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997 1.77
10 CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int 1997 1.57
11 Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995 1.53
12 The systemic distribution of soluble antigen injected into the footpad of the laboratory rat. Immunology 1970 1.51
13 Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 1996 1.51
14 Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med 1978 1.45
15 Chronic thoracic duct fistula: operative technic and physiologic effects in man. Ann Surg 1968 1.42
16 The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997 1.42
17 Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985 1.40
18 A broadening of vision: observation on the practice of surgery in a university hospital in Great Britain. Surgery 1974 1.39
19 Non-heartbeating kidney donors. Clin Transplant 1999 1.37
20 Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A 1995 1.34
21 Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation 1981 1.28
22 Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg 1973 1.28
23 The sensitization of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med 1971 1.27
24 Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation 1992 1.26
25 Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 1999 1.24
26 Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993 1.24
27 Small intestine transplantation in the rat--immunology and function. Surgery 1984 1.23
28 Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998 1.22
29 Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999 1.22
30 Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci U S A 1986 1.21
31 Peripheral arterial complications of intra-aortic ballon counterpulsation. Surgery 1977 1.16
32 Suppressive effects of cyclosporin A on the induction of alloreactivity in vitro and in vivo. J Immunol 1981 1.15
33 Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol 1987 1.13
34 Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment. Transplantation 1981 1.13
35 Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol 1977 1.12
36 The immunosuppressive effect of thoracic duct drainage in human kidney transplantation. Ann Intern Med 1970 1.12
37 Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation 1979 1.10
38 Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982 1.10
39 Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol 1998 1.10
40 Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats. Transplantation 1975 1.08
41 Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997 1.07
42 Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992 1.05
43 Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000 1.05
44 Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 1997 1.04
45 Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation 1983 1.04
46 Chronic graft rejection. Curr Opin Immunol 1994 1.02
47 Femoral triangle sepsis in dialysis patients: frequency, management, and outcome. Ann Surg 1980 1.02
48 Early experience with anti-Tac in clinical renal transplantation. Transplant Proc 1989 1.01
49 Hemorrhagic pancreatitis. A fatal complication of renal transplantation. N Engl J Med 1966 1.00
50 The cost of misadventures in colonic surgery. A model for the analysis of adverse outcomes in standard procedures. Am J Surg 1978 1.00
51 Treatment of chronic renal failure by transplantation and dialysis: two decades of cooperation. Ann Surg 1975 1.00
52 The migration of rat lymphoid cells into skin grafts. Some sensitised cells localise preferentially in specific allografts. Transplantation 1974 1.00
53 The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Clin Exp Immunol 1976 0.99
54 Mechanisms of rejection and prolongation of vascularized organ allografts. Immunol Rev 1984 0.99
55 The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation. Transplantation 1967 0.99
56 Urologic complications in 718 renal transplant patients. Surgery 1984 0.97
57 Colonic perforations after renal transplantation. J Am Coll Surg 1997 0.96
58 Natural history of the leg amputee. Am J Surg 1977 0.96
59 Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000 0.96
60 Renal transplantation: a twenty-five year experience. Ann Surg 1976 0.95
61 Immunoglobulin-secreting cells recovered from rejected human renal allografts. Transplantation 1982 0.95
62 Sparing of suppressor cells: a critical action of cyclosporine. Transplantation 1984 0.94
63 Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000 0.94
64 CD4 monoclonal antibodies in organ transplantation--a review of progress. Transplantation 1991 0.94
65 Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 1998 0.93
66 Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994 0.93
67 Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. J Immunol 1984 0.93
68 Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994 0.93
69 Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000 0.92
70 Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 1995 0.92
71 Experience with cyclosporine and steroids in clinical renal transplantation. Ann Surg 1984 0.92
72 Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 1997 0.92
73 Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. Transplant Proc 1991 0.92
74 Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 1994 0.91
75 Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allografts. Surgery 1976 0.91
76 Infiltration patterns of macrophages and lymphocytes in chronically rejecting rat kidney allografts. Transpl Int 1994 0.91
77 A twenty year survey of arterial complications of renal transplantation. Surg Gynecol Obstet 1975 0.91
78 Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997 0.90
79 Transfer of specific unresponsiveness to organ allografts by thymocytes. Specific unresponsiveness by thymocyte transfer. J Exp Med 1979 0.90
80 Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant 2000 0.90
81 Controlled clinical trial of antilymphocyte globulin in human renal allografts. Transplant Proc 1971 0.90
82 The different migratory characteristics of lymphocyte populations from a whole spleen transplant. Clin Exp Immunol 1975 0.90
83 Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. Kidney Int 1998 0.90
84 A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplantation 1991 0.89
85 Long-term results of cyclosporine treatment in renal transplantation. Transplant Proc 1986 0.89
86 Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001 0.89
87 Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A. J Immunol 1982 0.88
88 T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates. Lab Invest 1976 0.88
89 Recognition of self within self: specific lymphocyte positioning and the extracellular matrix. Immunol Today 1991 0.88
90 Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995 0.87
91 The importance of lymphocyte migration patterns in experimental organ transplantation. Transplantation 1985 0.87
92 Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001 0.87
93 A model of gradual onset brain death for transplant-associated studies in rats. Transplantation 2000 0.87
94 The influence of donor brain death on short and long-term outcome of solid organ allografts. Ann Transplant 2000 0.86
95 Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation 1991 0.86
96 Mechanisms of chronic rejection. Curr Opin Immunol 2000 0.86
97 Lymphocyte migration patterns in organ allograft recipients. Immunol Rev 1989 0.85
98 Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts. Transplantation 1985 0.85
99 Adhesion molecules and transplantation. Ann Surg 1994 0.85
100 Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells. J Immunol 1982 0.85
101 Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats. Transplantation 1992 0.85
102 Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation. Transplantation 1997 0.85
103 Ludwik Rydygier and the first gastrectomy for peptic ulcer. Surg Gynecol Obstet 1991 0.84
104 Chronic allograft failure: the clinical problem. Am J Med Sci 1997 0.84
105 Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. J Immunol 1987 0.84
106 In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. Transplantation 1989 0.84
107 Chronic rejection: increasing evidence for the importance of allogen-independent factors. Transplant Proc 1998 0.84
108 Liver disease in recipients of long-functioning renal allografts. Kidney Int 1985 0.83
109 Physiologic and histologic changes in the lungs of patients dying after prolonged cardiopulmonary bypass: an inquiry into the nature of post-perfusion lung. Ann Surg 1967 0.83
110 Late development of intractable lymphocele after renal transplantation. Transplant Proc 1988 0.83
111 Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms. Transplantation 1992 0.83
112 Acute renal failure in surgical patients. Causes, clinical patterns, and care. Surg Clin North Am 1983 0.83
113 W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts. J Immunol 1987 0.82
114 Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype. Transplant Proc 1988 0.82
115 The extent of immunological injury to the vasculature of cardiac allografts in the rat. Transplantation 1974 0.82
116 Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells. J Immunol 1989 0.82
117 Specificity of cellular migration into cardiac allografts in rats. Transplantation 1978 0.82
118 Adhesion molecule interaction with extracellular matrix. Exp Nephrol 1994 0.82
119 Thoracic duct fistula in human being renal transplantation. Surg Forum 1966 0.82
120 Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation 1985 0.82
121 Evaluation of renal transplants with ultrasound. Radiology 1976 0.82
122 Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation 1984 0.82
123 Function and migration of suppressor lymphocytes from cyclosporine-treated heart graft recipients. Transplantation 1983 0.82
124 Renal transplantation between identical twins: a review. World J Surg 1986 0.82
125 TNF as a mediator of cardiac transplant rejection, including effects on the intragraft protein C/protein S/thrombomodulin pathway. Transplant Proc 1991 0.82
126 Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance? J Immunol 1984 0.82
127 A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. Transplant Proc 1988 0.82
128 Migration patterns of lymphocytes in untreated and immunologically manipulated recipients of organ allografts. Transplantation 1982 0.81
129 Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody. Transplantation 1986 0.81
130 Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats. J Hypertens Suppl 1997 0.81
131 Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody. Transplantation 1989 0.81
132 Early cellular and molecular changes in ischemia/reperfusion injury: inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1. Transplant Proc 1997 0.81
133 Mechanisms of cardiac allograft prolongation by cyclosporin-A. Transplant Proc 1981 0.81
134 Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation. Transplantation 1988 0.81
135 Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts. Eur J Immunol 1987 0.81
136 Renal mass as a determinant of late allograft outcome: insights from experimental studies in rats. Kidney Int Suppl 1995 0.81
137 Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil. Transplantation 1996 0.81
138 Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection. Cell Immunol 1984 0.81
139 Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts. Transplant Proc 1987 0.81
140 Host leukocytes and their products in chronic kidney allograft rejection in rats. Transpl Int 1994 0.81
141 Activation of proinflammatory mediators in heart transplants from brain-dead donors: evidence from a model of chronic rat cardiac allograft rejection. Transplant Proc 2002 0.80
142 Accelerated graft dysfunction in renal isografts from non-heart-beating donors. Transplant Proc 2001 0.80
143 Interleukin 2 receptor--a target for immunosuppressive therapy. Transplant Rev (Orlando) 1987 0.80
144 Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture. Clin Immunol Immunopathol 1983 0.80
145 The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts. Transplantation 1990 0.80
146 Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia. Transplantation 1990 0.79
147 Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine. Transplantation 1983 0.79
148 Suppression of renal allograft rejection by low density thymocytes. Transplant Proc 1981 0.79
149 Immune responses to organ allografts. I. Intense B-cell response to heart allografts in lymphoid tissues of unmodified rats. Lab Invest 1979 0.79
150 Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Transplant Proc 1995 0.79
151 Host sensitization by alymphatic skin allografts in the rat. Surg Forum 1970 0.79
152 Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity. J Immunol 1985 0.79
153 The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats. Transplantation 1994 0.79
154 Renal allograft protection with losartan in Fisher-->Lewis rats: hemodynamics, macrophages, and cytokines. Kidney Int 2000 0.79
155 Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin. Am J Surg 1984 0.79
156 Identification, cytotoxicity, and suppressor activity of infiltrating cells from enhanced organ allografts. Transplant Proc 1977 0.79
157 Host-graft relationship: the systemic nature of allograft rejection. Surgery 1985 0.79
158 Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts. Transplantation 1995 0.78
159 Influence of initial antigen-independent events on acute allograft rejection: inhibition by a soluble P-selectin ligand and low-dose cyclosporine in combination. Transplant Proc 1998 0.78
160 Inhibition of rat skin allograft rejection by cyclosporine. In situ characterization of the impaired local immune response. Transplantation 1986 0.78
161 Harvey Cushing and his books. Surg Gynecol Obstet 1989 0.78
162 Renal artery stenosis in transplant patients. Ann Surg 1984 0.78
163 Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination. Transplantation 1999 0.78
164 Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. Transplant Proc 1993 0.78
165 Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection. Transplant Proc 1992 0.78
166 Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. Transplantation 1991 0.78
167 Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2. Transplantation 1982 0.78
168 Mycotic aneurysm from unrecognised colonic sepsis. J R Coll Surg Edinb 1977 0.78
169 Prolongation of organ allograft survival by syngeneic lymphoid cells. J Immunol 1978 0.78
170 Successful heterotopic heart transplantation in rat. Microsurgery 1994 0.78
171 Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects. J Exp Med 1988 0.78
172 Acute lead neuropathy: tracheo-innominate fistula. J R Coll Surg Edinb 1975 0.77
173 The influence of donor brain death on long-term function of renal allotransplants in rats. Transplant Proc 2001 0.77
174 Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts. Transplantation 1989 0.77
175 Effect of RS61443 on chronic rejection of rat kidney allografts. Transplant Proc 1995 0.77
176 Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo. Transplant Proc 1989 0.77
177 Immune and nonimmune mechanisms of chronic rejection of kidney allografts. J Heart Lung Transplant 1996 0.77
178 Initial ischemia/reperfusion injury influences late functional and structural changes in the kidney. Transplant Proc 1997 0.77
179 The detection of cardiac allograft rejection by alterations in proton NMR relaxation times. Invest Radiol 1985 0.77
180 Management of general surgical complications following cardiac transplantation. Arch Surg 1989 0.77
181 Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms. Transplantation 1990 0.77
182 Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat. Cell Immunol 1985 0.77
183 Enhanced allograft survival by combined active and passive immunization. Requirement of both erythrocytes and leukocytes. Transplantation 1978 0.77
184 Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats. Proc Assoc Am Physicians 1996 0.77
185 Cerebromeningitis in immunosuppressed recipients of renal allografts. Ann Surg 1982 0.77
186 Improvements in early behaviour of kidney allografts after donor treatment. Transplant Proc 2002 0.77
187 The relationship between reduced functioning kidney mass and chronic rejection in rats. Transpl Int 1994 0.76
188 Neutrophils and macrophages are prominent in the pathophysiology of chronic rejection of rat kidney allografts. Transplant Proc 1993 0.76
189 Hepatic abscess produced by extension of a perinephric abscess. Am J Surg 1972 0.76
190 Infection-associated cellular activation accelerates chronic renal allograft rejection in rats. Transpl Int 1996 0.76
191 Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy. Transplantation 1991 0.76
192 Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transplant Proc 1999 0.76
193 The marrow of the tragedy (Harvey Cushing). Surg Gynecol Obstet 1983 0.76
194 Differential effects of heterologous antisera on the survival of cardiac and skin allografts in rats. Transplantation 1981 0.76
195 Anti-Ia antibody eluted from rejected human renal allografts. Transplant Proc 1978 0.76
196 Antibody-mediated rejection of organ grafts. Curr Opin Immunol 1991 0.76
197 Early and late inflammatory changes occurring in rat renal isografts from brain dead donors. Transplant Proc 2001 0.76
198 A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation. Transplant Proc 1991 0.76
199 Host response to implanted dacron grafts. A comparison between mesh and velour. Arch Surg 1975 0.75
200 Use of living donors in renal transplantation. Transplant Rev (Orlando) 1987 0.75
201 Reversal of allograft rejection. Ann Thorac Surg 1994 0.75
202 Ultrasound in renal transplantation. Ann Surg 1977 0.75
203 Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A. Dev Biol Stand 1988 0.75
204 Calyceal-cutaneous fistulae in renal transplant patients. Ann Surg 1976 0.75
205 Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats. Transplantation 1993 0.75
206 Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts. Proc Natl Acad Sci U S A 1990 0.75
207 Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection. Transplantation 1996 0.75
208 A year's fellowship in America. Ann R Coll Surg Engl 1977 0.75
209 Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin. Immunobiology 1986 0.75
210 A semi-centennial report on the participants depicted in Joel Babb's portrait, 'the first successful kidney transplantation'. Am J Transplant 2007 0.75
211 Migration patterns of lymphocytes from recipients of organ allografts. I. The unmodified host. Transplantation 1981 0.75
212 A longitudinal study of bone disease after successful renal transplantation. Nephron 1978 0.75
213 The treatment of chronic renal failure by transplantation. J Dial 1977 0.75
214 [Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis]. Postepy Hig Med Dosw 1992 0.75
215 Populations of infiltrating cells removed from rejecting rat cardiac allografts. Surg Forum 1974 0.75
216 Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts. Transplantation 1988 0.75
217 The antigenicity of electrocauterized allogeneic tumor cells in mice. J Surg Res 1982 0.75
218 Host response to cardiac allografts in rats. Effect of thymectomy, irradiation, T cell depletion, or AgB compatibility. J Surg Res 1976 0.75
219 Microangiography of the white pulp of the spleen. Am J Roentgenol Radium Ther Nucl Med 1975 0.75
220 Suppression of lymph node CTL generation by spleen cells from cyclosporine-treated cardiac-allografted rats. Transplant Proc 1987 0.75
221 Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts. Transplant Proc 1990 0.75
222 Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats. Transplant Proc 1994 0.75
223 The original Peter Bent Brigham Hospital surgical staff. Surg Gynecol Obstet 1981 0.75
224 A characterization of the nature and control of cellular allograft rejection. Nephron 1978 0.75
225 Conservative management of the failed renal allograft: indications for transplant nephrectomy. Curr Surg 1983 0.75
226 Selective localization of cortical thymocytes to cardiac allografts in enhanced rats. Transplantation 1982 0.75
227 Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts. Transplant Proc 1991 0.75
228 Nonimmune factors may contribute to chronic rejection of kidney transplants. Transplant Proc 1994 0.75
229 Kallikrein excretion in renal transplant recipients and in uninephrectomized donors. Kidney Int 1985 0.75
230 Successful management of catastrophic intraabdominal complications following cardiac transplantation. Transplant Proc 1989 0.75
231 The character of effector cells and the accumulation of macrophages in rejecting heart allografts in the rat. Br J Surg 1973 0.75
232 Variant forms of arteritis in human renal allografts. Transplant Proc 1979 0.75
233 Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts. Transplant Proc 1989 0.75
234 Influence of selective splenectomy on survival of cardiac and skin allografts in enhanced rats. Transplantation 1980 0.75
235 Vascular access for dialysis and cancer chemotherapy. Adv Surg 1986 0.75
236 Prolonged allograft survival following cell transfusions. Surg Forum 1977 0.75
237 T cell activation antigens: therapeutic implications. Immunol Invest 1988 0.75
238 Cushing, Cutler and the mitral valve. Surg Gynecol Obstet 1981 0.75
239 Kidney transplantation in the treatment of terminal uremia. Ann Clin Res 1981 0.75
240 Medispeak. N Engl J Med 1977 0.75
241 The effect of T-cell depletion on host responses to organ allografts. Transplant Proc 1979 0.75
242 Harvey Cushing and the surgical research laboratory. Surg Gynecol Obstet 1980 0.75
243 Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness. Transplantation 1985 0.75
244 Proceedings: passive enhancement of heterotopic rat heart transplants. Br J Surg 1973 0.75
245 Systemic hypertension accelerates chronic rejection of renal allografts in the rat. Transplant Proc 1999 0.75
246 Monoclonal anti-T12 antibody as therapy for renal allograft rejection. Trans Assoc Am Physicians 1983 0.75
247 Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network. Transplant Proc 1989 0.75
248 In support of having your operation where there is training of surgical residents. Arch Surg 1981 0.75
249 Alloantigen-independent factors lead to signs of chronic rejection in long-term kidney isografts. Transpl Int 1994 0.75
250 Rehabilitation profile of kidney transplant patients. Am J Surg 1978 0.75
251 Proceedings: Nature of cells removed from rejecting rat cardiac allografts;. Br J Surg 1975 0.75
252 Prolonged survival of alymphatic skin allografts in the rat. A humoral component. Transplantation 1978 0.75
253 Harvey Cushing and the evolution of a polymath. Surg Gynecol Obstet 1986 0.75
254 Insights into acute and chronic rejection. Transplant Proc 1996 0.75
255 Intragraft immune events causing vascularized organ graft rejection. Transplant Proc 1978 0.75
256 Influence of renal mass on chronic kidney allograft rejection in rats. Transplant Proc 1995 0.75
257 Leg trauma with posterior tibial artery tear. J Trauma 1967 0.75
258 Immune responsiveness following skin grafting in cyclosporine-treated rats. Transplant Proc 1987 0.75
259 Modified immune responses of T-cell-depleted rats to vascularly anastomosed organ grafts. Surg Forum 1978 0.75
260 Host cell proliferation in response to skin allografts on alymphatic pedicles. Cell Immunol 1974 0.75
261 Prolongation of survival and preservation of allograft structure and function by a signaling CD28 mAB in a rat model of chronic kidney rejection. Transplant Proc 2001 0.75
262 The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. Transplantation 1992 0.75
263 Patterns of thymocyte migration in unmodified and enhanced recipients of cardiac allografts. Surg Forum 1979 0.75
264 Antigen-independent events mimic characteristic changes of chronic allograft rejection. Transplant Proc 1995 0.75
265 T cells and their products in host responsiveness to organ allografts. Prog Clin Biol Res 1986 0.75
266 The technique of transsternal thymectomy in the puppy. Transplantation 1969 0.75
267 Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat. Transplant Proc 1987 0.75
268 Cyclosporine and experimental skin allografts: long-term survival in rats treated with low maintenance doses. Plast Reconstr Surg 1986 0.75
269 A humoral component in prolongation of alymphatic skin allografts in rats. Surg Forum 1976 0.75
270 Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. Transplant Proc 1997 0.75
271 Severe temporary deterioration of renal transplant function following meningococcemia. Transplant Proc 1971 0.75
272 Transfer of specific unresponsiveness to organ allografts by thymocytes. J Am Soc Nephrol 1999 0.75
273 In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic. Trans Assoc Am Physicians 1989 0.75
274 The capacity of lymphocytes from recipients of acutely rejecting allografts to modulate macrophage plasminogen activator activity. Transplantation 1981 0.75
275 W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients. Transplant Proc 1987 0.75
276 Stability of renal allograft recipients after conversion from cyclosporine to azathioprine. Transplant Proc 1985 0.75
277 Use of an ectopic pelvic donor kidney for transplantation. Transplant Proc 1984 0.75
278 Treatment with anti-interleukin-2 receptor monoclonal antibody. Prog Clin Biol Res 1986 0.75
279 Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors. Transplant Proc 1995 0.75
280 T suppressor lymphocytes reverse ongoing acute allograft rejection. Hum Immunol 1985 0.75
281 Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts. Clin Nephrol 1996 0.75
282 Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival. Transplant Proc 1992 0.75
283 Studies on living cells harvested from acutely rejecting and enhanced rat cardiac allografts. Surg Forum 1975 0.75
284 Dissolution of allograft collecting system following hemorrhagic pancreatitis. Transplant Proc 1982 0.75
285 Carl Walter and the evolution of the Surgical Research Laboratory: 1937 through 1949. Am J Surg 1984 0.75
286 [The first successful transplantation of the kidney--already a part of the history of medicine]. Wiad Lek 1985 0.75
287 Characteristic signs of chronic allograft rejection can be observed in mechanically manipulated naive rat kidneys over the long-term. Transplant Proc 1995 0.75
288 The role of leukocyte adhesion molecules in acute transplant rejection. Curr Opin Nephrol Hypertens 1994 0.75
289 Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation. Cell Immunol 1989 0.75
290 Studies on mechanisms of acute rejection of vascularized organ allografts. Hum Immunol 1986 0.75
291 Human renal kallikrein-kinin system after engraftment and/or immunosuppression. Prog Clin Biol Res 1989 0.75
292 Suppressor cells influence maintenance and reversal of late rejection in indefinitely surviving skin allografts in cyclosporine-treated rats. Transplant Proc 1988 0.75
293 Changes in lymphocyte migration patterns after heart grafting in rats. Transplant Proc 1981 0.75
294 Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18. Transplant Proc 1988 0.75
295 The accumulation of gallium-67-labeled leukocytes in rat cardiac allografts. J Surg Res 1976 0.75
296 Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation. Transplant Proc 1987 0.75
297 Anti-T12 monoclonal antibody therapy of acute renal allograft rejection. Transplant Proc 1987 0.75
298 [Cyclosporin A--a new immunosuppressive drug]. Pol Tyg Lek 1985 0.75
299 Financial compensation for cadaver organ donation: good idea or anathema. Transplant Proc 1993 0.75
300 Donor brain death affects tempo and intensity of acute rejection of rat chronic allografts. Transplant Proc 1999 0.75
301 Microangiopathic hemolytic anemia associated with hyperacute rejection of a kidney allograft. Transplant Proc 1982 0.75
302 Immune responses to organ allografts. II. Decreased B cell responses to cardiac allografts in rats pretreated with enhancing, suppressor cell, or T lymphocyte depletion protocols. Transplantation 1979 0.75
303 Current stage of interleukin 2 receptor targeted therapy. Exp Clin Endocrinol 1989 0.75
304 Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts. Transplant Proc 1999 0.75
305 Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats. Arch Immunol Ther Exp (Warsz) 1983 0.75
306 Acute rejection of rat renal allografts is accelerated by donor brain death. Transplant Proc 1999 0.75
307 Migration patterns of lymphocytes from recipients of organ allografts. II. The enhanced host. Transplantation 1983 0.75
308 Symposium: update on nutrition. Nutrition 1992 0.75
309 Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys. Transplant Proc 1977 0.75
310 Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats. Functional studies of heart and kidney allografts. Transplantation 1991 0.75
311 Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allografts. Transplant Proc 1988 0.75
312 Cytokines and adhesion molecules in chronic rejection. Clin Transplant 1994 0.75
313 Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats. Transplantation 1984 0.75
314 Suppressor cells in enhancement of organ allografts. Transplant Proc 1979 0.75
315 Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy. Transplant Proc 1981 0.75
316 Donor hypertension and recipient immune responsiveness in chronic rat cardiac allograft rejection. Transplant Proc 2001 0.75
317 The potential use of cyclosporine in reconstructive surgery. Plast Reconstr Surg 1985 0.75
318 Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats. Transplant Proc 1991 0.75
319 Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. Transplantation 1997 0.75
320 Harvey Cushing and the Oxford connection. Surg Gynecol Obstet 1982 0.75
321 Morphological changes in indefinitely surviving enhanced ectopic rat cardiac allografts. J Pathol 1976 0.75
322 [Immunosuppressive therapy in transplantation surgery]. Dtsch Med Wochenschr 1987 0.75
323 Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital. Am J Kidney Dis 1985 0.75
324 Prevention of chronic rejection of renal allografts in rats using a synthetic inhibitor of macrophage effector activation. Transplant Proc 1995 0.75
325 Binding of lymphocytes to acutely rejecting rat kidney allografts in vitro is guided by events in the graft itself rather than by sensitization of host lymphocytes. Transpl Immunol 1995 0.75
326 Transplantation without bilateral nephrectomy. J Urol 1974 0.75
327 Prevention of chronic rejection and puromycin-induced glomerulosclerosis in rats by gamma-lactone, an inhibitor of macrophage-effector activation. Transplant Proc 1996 0.75
328 Prompt treatment of initial acute rejection episodes may improve long-term graft outcome. Transpl Int 1998 0.75
329 Host-graft relationship in accelerated rejection of rat cardiac allografts. Transplant Proc 1989 0.75
330 An effective technique for management of transplant kidneys with polar branches. Arch Surg 1976 0.75
331 Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts. Transplant Proc 1988 0.75
332 Enhancement of cardiac allografts in rats. Comparison of host responses to different treatment protocols. Transplantation 1978 0.75
333 Effects of thymectomy, thoracic duct drainage, and radiation of T and B lymphocyte distribution and cardiac allograft survival in rats. Transplantation 1981 0.75
334 [Cyclosporin: experimental studies and clinical use in organ transplants]. Rev Invest Clin 1985 0.75
335 Early ischemic injury leads to long-term functional and morphologic deterioration of naive rat kidneys and may contribute to changes of chronic allograft rejection. Transplant Proc 1994 0.75
336 The use of percutaneous nephrostomy in patients with ureteric obstruction undergoing renal transplantation. Surg Gynecol Obstet 1986 0.75
337 Prolongation of skin allografts following transplantation of intact sensitized spleens. J Surg Res 1977 0.75
338 Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG. Transplant Proc 1981 0.75
339 Altered alloimmune response toward grafts from brain-dead donors in chronic rat cardiac allograft rejection. Transplant Proc 2001 0.75
340 Changes of chronic kidney allograft rejection are reversible after retransplantation. Transplant Proc 1993 0.75
341 Refined techniques for heterotopic cardiac transplantation in the rat. Transplant Proc 1989 0.75
342 Aqueous silver nitrate (0.5 percent) in the treatment of nonthermal war wounds. Arch Surg 1969 0.75
343 Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture. Transplantation 1990 0.75
344 Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts. Transplant Proc 1991 0.75
345 Systemic natural killer activity following cardiac engraftment in the rat: lack of correlation with graft survival. Cell Immunol 1986 0.75
346 Studies on enhancement of cardiac and renal allografts in the rat. Transplantation 1974 0.75